Brief: Quantum Genomics Completes Patient Recruitment In Phase IIB Hypertension Study

Quantum Genomics SA

07/09/2018 07:09

Sept 7 (Reuters) - QUANTUM GENOMICS  ALQGC.PA :
    * SAID ON THURSDAY IT COMPLETED PATIENT RECRUITMENT MORE
THAN SIX
MONTHS AHEAD OF INITIAL SCHEDULE IN ITS PHASE IIB HYPERTENSION
STUDY
    * EXPECTS TO PRESENT RESULTS BY MID-NOVEMBER 2018
    * NEW-HOPE RESULTS WILL REPRESENT A MAJOR MILESTONE IN
CLINICAL
DEVELOPMENT OF FIRIBASTAT AND MAY SUPPORT DESIGN OF FUTURE PHASE
III TRIAL

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nACT54892
    
 Further company coverage:  ALQGC.PA  
   


 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))